We are live on ! Find out more
ZAM

Zeal Asset Management Portfolio holdings

AUM $39.4M
1-Year Est. Return 38.83%
This Fund
S&P 500
This Quarter Est. Return
-3.94%
1 Year Est. Return
+38.83%
3 Year Est. Return
-26.89%
5 Year Est. Return
10 Year Est. Return
AUM
$20.8M
AUM Growth
-$22.4M
Cap. Flow
-$21M
Cap. Flow %
-101.32%
Top 10 Hldgs %
100%
Holding
3
New
Increased
1
Reduced
2
Closed

Top Buys

Rank Stock Value
1
LI icon
Li Auto
LI
+$818K

Top Sells

Rank Stock Value
1
ONC
BeOne Medicines Ltd
ONC
+$15.3M
2
ZLAB icon
Zai Lab
ZLAB
+$6.5M

Sector Composition

Rank Sector Weight
1 Healthcare 77.16%
2 Consumer Discretionary 22.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
1
BeOne Medicines Ltd
ONC
$33.8B
$13.1M 63%
73,253
-66,651
-48% -$15.3M
LI icon
2
Li Auto
LI
$13.1B
$4.74M 22.84%
135,316
+29,085
+27% +$818K
ZLAB icon
3
Zai Lab
ZLAB
$2.1B
$2.94M 14.16%
106,171
-198,649
-65% -$6.5M

Similar funds

Zeal Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Zeal Asset Management held 3 positions worth $20.8M, down 52% from $43.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Zeal Asset Management withdrew a net $21M in Q2 2023, reducing 2 holdings. Its largest reduction was BeOne Medicines Ltd, cutting an estimated $15.3M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 94% a quarter earlier, followed by Consumer Discretionary.

Against the trend, Zeal Asset Management added an estimated $818K to Li Auto.

  • Zeal Asset Management added most to Li Auto in Q2 2023, an estimated $818K increase.
  • Zeal Asset Management's biggest Q2 2023 reduction was BeOne Medicines Ltd, cutting an estimated $15.3M.
  • Zeal Asset Management's ten largest holdings make up 100% of its $20.8M portfolio in Q2 2023.
  • Zeal Asset Management opened 0 new positions and closed 0 in Q2 2023.
  • Zeal Asset Management's portfolio value fell 52% quarter-over-quarter to $20.8M.

Based on Zeal Asset Management's 13F filing for Q2 2023, filed 31 Jul 2023.